EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

DIHYDROPYRIMIDINONE DERIVED CHALCONES AS EMERGING ANTICANCER SCAFFOLDS AGAINST A549 LUNG CANCER CELL LINES

Jagadeeswara Rao Batna, Nuziveeti Lakshmi Durga Bhavani, Dharmasoth Rama Devi, Prasanth Yarramsetti, Suknkari Vasanthi, Motupalli Sri Sai Supratheeka, Nukala Lalitha Naga Valli Sri Chandrika, Kiran Manda

Genetics and Molecular Research · 25.06.2026

DOI: 10.4238/7paz2p48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 25.06.2026. Verfasst von Jagadeeswara Rao Batna und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel dihydropyrimidnone chalcones were synthesized by using Clasein Schmidth condensation from 5-acetyl, 6-methyl, 4- (3- ethoxy, 4-hydroxy phenyl) dihyro pyrimidine-2-one by reacting with various substituted aldehydes. Their structural characterizations were evaluated by FT-IR, 1H NMR, 13C NMR, mass spectroscopy. They were screened for in vitro anticancer activity by using MTT assay against human lung cancercell lines (A-549). Dihydropyrimidnone chalcones CH4 (21± 2), CH13 (23± 2) and CH15 (18± 2) showed nearly equal potent with the standard drug Methothrexate (11± 2). Docking was done with crystalline protein structure of SAMDH1 which has rapid gene expression in lung cancer cell than other cancer cells. Amino acid residues GLY-159, ARG-160, ASP-94, TYR-39, GLY-40, HIS-53, of SAMHD1 were found to be directly interacting with the synthesized compounds. The most active compounds with dock scores (Kcal/mol) are as CH4= - 8.3, CH13 = -8.7, CH15 compared to Methothrexate (-6.10 kcal/mol) and these results have correlated with in vitro MIC values. Hence, these novel dihydropyrimidinone chalcones were considered as lead anti-cancer agents against lung cancer.

Zitieren

APA

Batna, J. R., Bhavani, N. L. D., Devi, D. R., Yarramsetti, P., Vasanthi, S., Supratheeka, M. S. S., Chandrika, N. L. N. V. S., & Manda, K. (2026). DIHYDROPYRIMIDINONE DERIVED CHALCONES AS EMERGING ANTICANCER SCAFFOLDS AGAINST A549 LUNG CANCER CELL LINES. Genetics and Molecular Research. https://doi.org/10.4238/7paz2p48

Vancouver

Batna JR, Bhavani NLD, Devi DR, Yarramsetti P, Vasanthi S, Supratheeka MSS, et al. DIHYDROPYRIMIDINONE DERIVED CHALCONES AS EMERGING ANTICANCER SCAFFOLDS AGAINST A549 LUNG CANCER CELL LINES. Genetics and Molecular Research. 2026. doi:10.4238/7paz2p48

BibTeX
@article{Batna2026,
  author = {Batna, Jagadeeswara Rao and Bhavani, Nuziveeti Lakshmi Durga and Devi, Dharmasoth Rama and Yarramsetti, Prasanth and Vasanthi, Suknkari and Supratheeka, Motupalli Sri Sai and Chandrika, Nukala Lalitha Naga Valli Sri and Manda, Kiran},
  title = {DIHYDROPYRIMIDINONE DERIVED CHALCONES AS EMERGING ANTICANCER SCAFFOLDS AGAINST A549 LUNG CANCER CELL LINES},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/7paz2p48}
}
Kostenlos starten →